期刊
FERTILITY AND STERILITY
卷 95, 期 3, 页码 900-905出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2010.10.020
关键词
High-intensity focused ultrasound; uterus; adenomyosis; ultrasound ablation; thermal ablation
资金
- National Natural Science Foundation of China [30830040, 30901234]
Objective: To assess the midterm outcomes after ultrasound-guided high-intensity focused ultrasound (HIFU) ablation in treatment of patients with symptomatic adenomyosis. Design: A prospective clinical trial. Setting: University teaching hospital. Patient(s): Seventy-eight patients with symptomatic adenomyosis. Intervention(s): A single treatment session of ultrasound-guided HIFU ablation for adenomyosis. Main Outcome Measure(s): Dysmenorrhea and menorrhagia scores and the incidence of complications. Result(s): In all 78 patients, 84.6% tolerated the treatment procedure well with pain scores between 0 and 4. Treatment was terminated in only one patient because of increased blood pressure persistently. Sixty-nine patients have finished at least an 18-month follow-up; the mean follow-up time was 24.2 months. Nonperfused regions in lesions were observed in 60 (87.0%) patients on the enhanced magnetic resonance imaging scans. Scores for menorrhea and dysmenorrhea decreased. Clinical effectiveness of the treatment was observed in 62 women (89.9%) with varying degrees of symptomatic relief of dysmenorrhea. Eight patients had relapses. Twenty-two patients (28.6%) had 27 complications. Of these, four had two or more complications. Twenty-three events (85.1%) did not need medical intervention (Society of Interventional Radiology class A). No serious complications including death or major permanent injuries were observed. Conclusion(s): Ultrasound-guided HIFU ablation may be a safe and effective noninvasive alternative in the treatment of symptomatic adenomyosis. (Fertil Steril (R) 2011; 95: 900-5. (C) 2011 by American Society for Reproductive Medicine.)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据